Cychlorphine: A New Synthetic Opioid Changing the Forensic Toxicology Landscape

A 16-year-old in San Francisco died in April 2026 after exposure to a combination of drugs that included cychlorphine, a newly emerging synthetic opioid.

What is cychlorphine?

Cychlorphine, also known as N-propionitrile chlorphine, is a novel synthetic opioid in the emerging “orphine” family. It is only recently appearing in forensic casework, and human toxicological data remain limited.

Why is it concerning?

🔬 Routine testing may miss it.
Emerging synthetic opioids may not be identified by conventional immunoassay screening and can require targeted mass-spectrometric or high-resolution testing.

💊 It can appear in counterfeit pills.
Counterfeit tablets may resemble legitimate medications, creating a risk for people who do not knowingly take opioids.

⚠️ Potency and toxicity require careful interpretation.
Public-health officials have described cychlorphine as substantially more potent than fentanyl. Because human toxicological data remain limited, reported potency estimates should not be treated as established human dose-toxicity relationships.

🧪 Forensic laboratories face a moving target.
Labs must continually evaluate emerging opioids, reference materials, metabolites, detection limits, and validated methods.

🧬 Metabolites may be important.
Understanding metabolism and appropriate biomarkers will be critical when parent-drug concentrations are low or specimens are limited.

The San Francisco case illustrates why this matters.

According to the San Francisco Police Department, the investigation into the April death led to the seizure of more than 20,000 counterfeit pills in September 2026. Authorities also reported finding cychlorphine in counterfeit pills from earlier investigations.

The American College of Medical Toxicology has also reported a biologically confirmed non-fatal cychlorphine overdose.

For forensic toxicologists, medical examiners, clinicians, law enforcement, and families, the message is clear: The drug landscape does not remain static. Neither can our toxicology testing.

When investigating an unexpected or unexplained overdose, emerging synthetic opioids must be considered even when routine screening does not provide an answer.

Our responsibility is not simply to identify what we expected to find.

It is to recognize when the unexpected may be present—and have the analytical tools and scientific knowledge to find it.

Forensic toxicology is constantly evolving. So must we.